Back to Market返回行情

TRNS Transcat, Inc.

USIndustrials
$88.41+0.07%ClosedMarket Cap: $825.8M

As of 2026-07-10 16:00

Why TRNS matters now

Transcat, Inc. (TRNS) is a US stock in Industrials. The latest InvestLog snapshot shows $88.41 with +0.07% on the session and $825.8M in market capitalization; recent performance reads 1-month +33.37% and YTD +63.72%.

The latest financial table shown here is Q4 2025, with revenue of $89.3M, net income of $1.9M, and EPS of $0.21. Investors can compare that operating picture with valuation signals such as P/E 77.48 and FCF yield 2.3%.

The latest indexable market news headline is "Transcat: Mission Critical Company With A Strong Moat" from Seeking Alpha.

Additional event context on this page matters because analyst consensus is Buy with a median target of $113.00; recent insider activity includes Rudow Lee D. filing M-Exempt. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

77.48

PEG

P/B

2.89

P/S

2.64

EV/EBITDA

26.13

DCF Value

$57.39

FCF Yield

2.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

32.7%

Operating Margin

3.9%

Net Margin

1.8%

ROE

2.0%

ROA

1.2%

ROIC

2.0%

Financials

PeriodRevenueNet IncomeEPS
Q4 2025$89.3M$1.9M$0.21
FY 2025$331.9M$5.4M$0.57
Q3 2026$73.3M$3.7M$0.41
Q2 2025$82.3M$1.3M$0.14

Analyst Ratings

Consensus

Buy

Target (Consensus)

$123.60

Target (Median)

$113.00

Target Range

$94.00 - $160.00

Strong Buy: 0Buy: 3Hold: 1Sell: 0Strong Sell: 0
HC Wainwright & Co.Buy
2025-08-26
HC Wainwright & Co.Buy
2025-06-25

Trading Activity

Insider Trades

Rudow Lee D.director, officer: President and CEO
Sell2026-06-11
Rudow Lee D.director, officer: President and CEO
Sell2026-06-11
Rudow Lee D.director, officer: President and CEO
Sell2026-06-11
Rudow Lee D.director, officer: President and CEO
Sell2026-06-11
Rudow Lee D.director, officer: President and CEO
Sell2026-06-11

Company Info

Sector

Industrials

Industry

Industrial - Distribution

Country

US

Exchange

Beta

0.70

Transcat, Inc. offers comprehensive calibration and instrument services for laboratories, serving clients across the United States, Canada, and other international markets. The company operates through two distinct divisions: Service and Distribution. The Service division delivers a wide array of offerings, including precision calibration, equipment repair, thorough inspections, analytical qualification, preventive maintenance, and expert consulting. This segment also features its proprietary software, CalTrak, designed to manage documents and assets while streamlining the operational workflow for its calibration centers and customer equipment. Additionally, its "Compliance, Control and Cost" online portal grants customers web-based asset management capabilities and a secure, off-site repository for calibration and other service records. The Distribution division focuses on the sale and rental of instruments for testing, measurement, and control purposes. It also provides valuable supplementary services such as the calibration and certification of newly purchased equipment, equipment leasing, sales of pre-owned machinery, and customized equipment kitting. This division engages customers through its online platform, various digital and print marketing campaigns, proactive outbound sales efforts, and an incoming call center. Transcat primarily caters to highly regulated sectors, particularly the life sciences—encompassing pharmaceutical, biotechnology, medical device, and other FDA-regulated entities. Furthermore, it extends its services and products to aerospace and defense, industrial manufacturing, energy, utilities, and other industries where process accuracy and confirmed equipment performance are paramount. Established in 1964, Transcat, Inc. maintains its corporate headquarters in Rochester, New York.